Cargando…

Open questions for Alzheimer’s disease immunotherapy

Perhaps more definitively than any other class of novel Alzheimer’s disease (AD) therapy, pre-clinical studies in mouse models of amyloid β (Aβ) deposition have established the disease-modifying potential of anti-Aβ immunotherapy. Despite disappointing results to date from anti-Aβ immunotherapy ther...

Descripción completa

Detalles Bibliográficos
Autor principal: Golde, Todd E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4056616/
https://www.ncbi.nlm.nih.gov/pubmed/24393284
http://dx.doi.org/10.1186/alzrt233